Remuneration Committee

Remuneration Committee

The remuneration is designated within the Board members and deals with matters concerning remuneration to Chief Executive Officer and senior officers. The remuneration committee consists of Pär-Ola Mannefred, chairman, Robert Marchesani and Anna Belfrage.

The Remuneration Committee has the following key responsibilities:

  • ● Prepare proposals to the Board of directors regarding the decision on remuneration, remuneration principles and other terms of employment for the executive management.
  • ● Analyze and evaluate variable remuneration, both ongoing and that has ended during the year, for the executive management.
  • ● Evaluate and monitor the remuneration guidelines in compliance with the Annual General Meeting that is required to be established by Swedish law.

Guidelines for remuneration to senior officers

The guidelines follow in essence the principles used up to this point. Senior officers are the persons that, together with the CEO, form Executive Management. Guidelines will be applicable for contracts of employment signed after the AGM decision on guidelines and for those cases in which alterations are made in existing contracts after the AGM decision. Isofol shall offer a total compensation on par with market levels so that the Company can recruit and retain qualified senior officers. Remuneration to senior officers consists of a basic wage, variable remuneration, other benefits and pension. The Group’s guidelines for remuneration to senior officers are available via the link below and they was adopted at the AGM June 24, 2020.

  The Board of Directors of Isofol Medical AB (publ) proposal for guidelines for remuneration to senior executives – approved at the Annual General Meeting 24 June 20200 (Swedish)

   Follow-up and evaluation of remuneration to the CEO and other senior executives 2019, (Swedish)